Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated December 22, 2023, with respect to the consolidated financial statements of Outlook Therapeutics, Inc., incorporated herein by reference.
/s/ KPMG LLP
Philadelphia, Pennsylvania
August 14, 2024
